EBOS Group has announced the appointment of Andrew McLean as CEO-Medical Technology, effective from 05 Aug 2024, according to an update on the ASX yesterday.
The appointment will see current CEO Matt Musico become a non-executive Director on 01 Jan 2025, while Peter Williams will shortly retire as a Board Director.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Jun 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Jun 24
